Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
January 29, 2016
Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal Models
Wei Wang, Subhasree Nag, Ruiwen Zhang
Journal of Biomedical Research
|
July 26, 2013
The MDM2-p53 pathway revisited
Subhasree Nag, Jiangjiang Qin, Kalkunte S Srivenugopal, et al.
Toxicology Letters
|
January 26, 2017
In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes
Jordan N Smith, Denis Mehinagic, Subhasree Nag, et al.
Medicinal Research Reviews
|
August 1, 2015
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, et al.
Medicinal Research Reviews
|
August 29, 2014
Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications
Wei Wang, Subhasree Nag, Xu Zhang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 8, 2014
A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study
Subhasree Nag, Jiang-Jiang Qin, Shivaputra Patil, et al.
Biochimica Et Biophysica Acta
|
July 30, 2014
NFAT as cancer target: mission possible?
Jiang-Jiang Qin, Subhasree Nag, Wei Wang, et al.
Oncotarget
|
October 26, 2014
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
Wei Wang, Jianwen Cheng, Jiang-Jiang Qin, et al.
Oncotarget
|
June 5, 2015
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
Sukesh Voruganti, Jiang-Jiang Qin, Sushanta Sarkar, et al.
Biomedical Chromatography : BMC
|
October 9, 2014
Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
Subhasree Nag, Jiang-Jiang Qin, Sukesh Voruganti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
January 29, 2016
Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal Models
Wei Wang, Subhasree Nag, Ruiwen Zhang
Journal of Biomedical Research
|
July 26, 2013
The MDM2-p53 pathway revisited
Subhasree Nag, Jiangjiang Qin, Kalkunte S Srivenugopal, et al.
Toxicology Letters
|
January 26, 2017
In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes
Jordan N Smith, Denis Mehinagic, Subhasree Nag, et al.
Medicinal Research Reviews
|
August 1, 2015
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, et al.
Medicinal Research Reviews
|
August 29, 2014
Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications
Wei Wang, Subhasree Nag, Xu Zhang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 8, 2014
A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido[b]indole anticancer agent, and its application to a mouse PK study
Subhasree Nag, Jiang-Jiang Qin, Shivaputra Patil, et al.
Biochimica Et Biophysica Acta
|
July 30, 2014
NFAT as cancer target: mission possible?
Jiang-Jiang Qin, Subhasree Nag, Wei Wang, et al.
Oncotarget
|
October 26, 2014
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
Wei Wang, Jianwen Cheng, Jiang-Jiang Qin, et al.
Oncotarget
|
June 5, 2015
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
Sukesh Voruganti, Jiang-Jiang Qin, Sushanta Sarkar, et al.
Biomedical Chromatography : BMC
|
October 9, 2014
Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
Subhasree Nag, Jiang-Jiang Qin, Sukesh Voruganti, et al.
Page
of 2